カテゴリー： Market Monitor Global, 世界, 医療/バイオ

止血製品の世界市場見通し2023年-2029年

◆英語タイトル：Hemostatic Product Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU4923）

◆商品コード：MMG23JU4923
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：62
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療機器＆消耗品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Hemostatic Product Market 調査レポートは次の情報を含め、グローバルにおけるの止血製品市場規模と予測を収録しています。・世界の止血製品市場：売上、2018年-2023年、2024年-2029年
・世界の止血製品市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の止血製品市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「外傷用止血製品」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

止血製品のグローバル主要企業は、Medtronic、 Johnson & Johnson、 Baxter International、 Pfizer Inc.、 Becton Dickinson and Company (BD)、 B. Braun Melsungen AG、 Tricol Biomedical、 Hemostasis LL、 Teleflex Incorporated、 CuraMedical BVなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、止血製品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の止血製品市場：タイプ別、2018年-2023年、2024年-2029年
世界の止血製品市場：タイプ別市場シェア、2022年
・外傷用止血製品、手術用止血製品、血友病用止血製品、心筋梗塞用止血製品、その他

世界の止血製品市場：用途別、2018年-2023年、2024年-2029年
世界の止血製品市場：用途別市場シェア、2022年
・病院、クリニック、その他

世界の止血製品市場：地域・国別、2018年-2023年、2024年-2029年
世界の止血製品市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における止血製品のグローバル売上、2018年-2023年
・主要企業における止血製品のグローバル売上シェア、2022年
・主要企業における止血製品のグローバル販売量、2018年-2023年
・主要企業における止血製品のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Medtronic、 Johnson & Johnson、 Baxter International、 Pfizer Inc.、 Becton Dickinson and Company (BD)、 B. Braun Melsungen AG、 Tricol Biomedical、 Hemostasis LL、 Teleflex Incorporated、 CuraMedical BV

*************************************************************

・調査・分析レポートの概要
止血製品市場の定義
市場セグメント
世界の止血製品市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の止血製品市場規模
世界の止血製品市場規模：2022年 VS 2029年
世界の止血製品市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの止血製品の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の止血製品製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：外傷用止血製品、手術用止血製品、血友病用止血製品、心筋梗塞用止血製品、その他
止血製品のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、クリニック、その他
止血製品の用途別グローバル売上・予測

・地域別市場分析
地域別止血製品市場規模 2022年と2029年
地域別止血製品売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Medtronic、 Johnson & Johnson、 Baxter International、 Pfizer Inc.、 Becton Dickinson and Company (BD)、 B. Braun Melsungen AG、 Tricol Biomedical、 Hemostasis LL、 Teleflex Incorporated、 CuraMedical BV
...

Products for hemostasis, including physical hemostasis, chemical hemostasis, etc.
This report aims to provide a comprehensive presentation of the global market for Hemostatic Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostatic Product. This report contains market size and forecasts of Hemostatic Product in global, including the following market information:
Global Hemostatic Product Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Hemostatic Product market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Hemostasis Products for Trauma Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hemostatic Product include Medtronic, Johnson & Johnson, Baxter International, Pfizer Inc., Becton Dickinson and Company (BD), B. Braun Melsungen AG, Tricol Biomedical, Hemostasis LL and Teleflex Incorporated, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hemostatic Product companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hemostatic Product Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Hemostatic Product Market Segment Percentages, by Type, 2022 (%)
Hemostasis Products for Trauma
Hemostasis Products for Surgery
Hemostasis Products for Hemophilia
Hemostasis Products for Myocardial Infarction
Others
Global Hemostatic Product Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Hemostatic Product Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Hemostatic Product Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Hemostatic Product Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hemostatic Product revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Hemostatic Product revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Johnson & Johnson
Baxter International
Pfizer Inc.
Becton Dickinson and Company (BD)
B. Braun Melsungen AG
Tricol Biomedical
Hemostasis LL
Teleflex Incorporated
CuraMedical BV
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hemostatic Product, market overview.
Chapter 2: Global Hemostatic Product market size in revenue.
Chapter 3: Detailed analysis of Hemostatic Product company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hemostatic Product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Hemostatic Product Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hemostatic Product Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hemostatic Product Overall Market Size
2.1 Global Hemostatic Product Market Size: 2022 VS 2029
2.2 Global Hemostatic Product Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hemostatic Product Players in Global Market
3.2 Top Global Hemostatic Product Companies Ranked by Revenue
3.3 Global Hemostatic Product Revenue by Companies
3.4 Top 3 and Top 5 Hemostatic Product Companies in Global Market, by Revenue in 2022
3.5 Global Companies Hemostatic Product Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hemostatic Product Players in Global Market
3.6.1 List of Global Tier 1 Hemostatic Product Companies
3.6.2 List of Global Tier 2 and Tier 3 Hemostatic Product Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Hemostatic Product Market Size Markets, 2022 & 2029
4.1.2 Hemostasis Products for Trauma
4.1.3 Hemostasis Products for Surgery
4.1.4 Hemostasis Products for Hemophilia
4.1.5 Hemostasis Products for Myocardial Infarction
4.1.6 Others
4.2 By Type – Global Hemostatic Product Revenue & Forecasts
4.2.1 By Type – Global Hemostatic Product Revenue, 2018-2023
4.2.2 By Type – Global Hemostatic Product Revenue, 2024-2029
4.2.3 By Type – Global Hemostatic Product Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Hemostatic Product Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application – Global Hemostatic Product Revenue & Forecasts
5.2.1 By Application – Global Hemostatic Product Revenue, 2018-2023
5.2.2 By Application – Global Hemostatic Product Revenue, 2024-2029
5.2.3 By Application – Global Hemostatic Product Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Hemostatic Product Market Size, 2022 & 2029
6.2 By Region – Global Hemostatic Product Revenue & Forecasts
6.2.1 By Region – Global Hemostatic Product Revenue, 2018-2023
6.2.2 By Region – Global Hemostatic Product Revenue, 2024-2029
6.2.3 By Region – Global Hemostatic Product Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Hemostatic Product Revenue, 2018-2029
6.3.2 US Hemostatic Product Market Size, 2018-2029
6.3.3 Canada Hemostatic Product Market Size, 2018-2029
6.3.4 Mexico Hemostatic Product Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Hemostatic Product Revenue, 2018-2029
6.4.2 Germany Hemostatic Product Market Size, 2018-2029
6.4.3 France Hemostatic Product Market Size, 2018-2029
6.4.4 U.K. Hemostatic Product Market Size, 2018-2029
6.4.5 Italy Hemostatic Product Market Size, 2018-2029
6.4.6 Russia Hemostatic Product Market Size, 2018-2029
6.4.7 Nordic Countries Hemostatic Product Market Size, 2018-2029
6.4.8 Benelux Hemostatic Product Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Hemostatic Product Revenue, 2018-2029
6.5.2 China Hemostatic Product Market Size, 2018-2029
6.5.3 Japan Hemostatic Product Market Size, 2018-2029
6.5.4 South Korea Hemostatic Product Market Size, 2018-2029
6.5.5 Southeast Asia Hemostatic Product Market Size, 2018-2029
6.5.6 India Hemostatic Product Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Hemostatic Product Revenue, 2018-2029
6.6.2 Brazil Hemostatic Product Market Size, 2018-2029
6.6.3 Argentina Hemostatic Product Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Hemostatic Product Revenue, 2018-2029
6.7.2 Turkey Hemostatic Product Market Size, 2018-2029
6.7.3 Israel Hemostatic Product Market Size, 2018-2029
6.7.4 Saudi Arabia Hemostatic Product Market Size, 2018-2029
6.7.5 UAE Hemostatic Product Market Size, 2018-2029
7 Hemostatic Product Companies Profiles
7.1 Medtronic
7.1.1 Medtronic Company Summary
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Hemostatic Product Major Product Offerings
7.1.4 Medtronic Hemostatic Product Revenue in Global Market (2018-2023)
7.1.5 Medtronic Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Hemostatic Product Major Product Offerings
7.2.4 Johnson & Johnson Hemostatic Product Revenue in Global Market (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 Baxter International
7.3.1 Baxter International Company Summary
7.3.2 Baxter International Business Overview
7.3.3 Baxter International Hemostatic Product Major Product Offerings
7.3.4 Baxter International Hemostatic Product Revenue in Global Market (2018-2023)
7.3.5 Baxter International Key News & Latest Developments
7.4 Pfizer Inc.
7.4.1 Pfizer Inc. Company Summary
7.4.2 Pfizer Inc. Business Overview
7.4.3 Pfizer Inc. Hemostatic Product Major Product Offerings
7.4.4 Pfizer Inc. Hemostatic Product Revenue in Global Market (2018-2023)
7.4.5 Pfizer Inc. Key News & Latest Developments
7.5 Becton Dickinson and Company (BD)
7.5.1 Becton Dickinson and Company (BD) Company Summary
7.5.2 Becton Dickinson and Company (BD) Business Overview
7.5.3 Becton Dickinson and Company (BD) Hemostatic Product Major Product Offerings
7.5.4 Becton Dickinson and Company (BD) Hemostatic Product Revenue in Global Market (2018-2023)
7.5.5 Becton Dickinson and Company (BD) Key News & Latest Developments
7.6 B. Braun Melsungen AG
7.6.1 B. Braun Melsungen AG Company Summary
7.6.2 B. Braun Melsungen AG Business Overview
7.6.3 B. Braun Melsungen AG Hemostatic Product Major Product Offerings
7.6.4 B. Braun Melsungen AG Hemostatic Product Revenue in Global Market (2018-2023)
7.6.5 B. Braun Melsungen AG Key News & Latest Developments
7.7 Tricol Biomedical
7.7.1 Tricol Biomedical Company Summary
7.7.2 Tricol Biomedical Business Overview
7.7.3 Tricol Biomedical Hemostatic Product Major Product Offerings
7.7.4 Tricol Biomedical Hemostatic Product Revenue in Global Market (2018-2023)
7.7.5 Tricol Biomedical Key News & Latest Developments
7.8 Hemostasis LL
7.8.1 Hemostasis LL Company Summary
7.8.2 Hemostasis LL Business Overview
7.8.3 Hemostasis LL Hemostatic Product Major Product Offerings
7.8.4 Hemostasis LL Hemostatic Product Revenue in Global Market (2018-2023)
7.8.5 Hemostasis LL Key News & Latest Developments
7.9 Teleflex Incorporated
7.9.1 Teleflex Incorporated Company Summary
7.9.2 Teleflex Incorporated Business Overview
7.9.3 Teleflex Incorporated Hemostatic Product Major Product Offerings
7.9.4 Teleflex Incorporated Hemostatic Product Revenue in Global Market (2018-2023)
7.9.5 Teleflex Incorporated Key News & Latest Developments
7.10 CuraMedical BV
7.10.1 CuraMedical BV Company Summary
7.10.2 CuraMedical BV Business Overview
7.10.3 CuraMedical BV Hemostatic Product Major Product Offerings
7.10.4 CuraMedical BV Hemostatic Product Revenue in Global Market (2018-2023)
7.10.5 CuraMedical BV Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Hemostatic Product Market Opportunities & Trends in Global Market
Table 2. Hemostatic Product Market Drivers in Global Market
Table 3. Hemostatic Product Market Restraints in Global Market
Table 4. Key Players of Hemostatic Product in Global Market
Table 5. Top Hemostatic Product Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Hemostatic Product Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Hemostatic Product Revenue Share by Companies, 2018-2023
Table 8. Global Companies Hemostatic Product Product Type
Table 9. List of Global Tier 1 Hemostatic Product Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hemostatic Product Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Hemostatic Product Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Hemostatic Product Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Hemostatic Product Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Hemostatic Product Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Hemostatic Product Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Hemostatic Product Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Hemostatic Product Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Hemostatic Product Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Hemostatic Product Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Hemostatic Product Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Hemostatic Product Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Hemostatic Product Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Hemostatic Product Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Hemostatic Product Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Hemostatic Product Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Hemostatic Product Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Hemostatic Product Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Hemostatic Product Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Hemostatic Product Revenue, (US$, Mn), 2024-2029
Table 30. Medtronic Company Summary
Table 31. Medtronic Hemostatic Product Product Offerings
Table 32. Medtronic Hemostatic Product Revenue (US$, Mn) & (2018-2023)
Table 33. Medtronic Key News & Latest Developments
Table 34. Johnson & Johnson Company Summary
Table 35. Johnson & Johnson Hemostatic Product Product Offerings
Table 36. Johnson & Johnson Hemostatic Product Revenue (US$, Mn) & (2018-2023)
Table 37. Johnson & Johnson Key News & Latest Developments
Table 38. Baxter International Company Summary
Table 39. Baxter International Hemostatic Product Product Offerings
Table 40. Baxter International Hemostatic Product Revenue (US$, Mn) & (2018-2023)
Table 41. Baxter International Key News & Latest Developments
Table 42. Pfizer Inc. Company Summary
Table 43. Pfizer Inc. Hemostatic Product Product Offerings
Table 44. Pfizer Inc. Hemostatic Product Revenue (US$, Mn) & (2018-2023)
Table 45. Pfizer Inc. Key News & Latest Developments
Table 46. Becton Dickinson and Company (BD) Company Summary
Table 47. Becton Dickinson and Company (BD) Hemostatic Product Product Offerings
Table 48. Becton Dickinson and Company (BD) Hemostatic Product Revenue (US$, Mn) & (2018-2023)
Table 49. Becton Dickinson and Company (BD) Key News & Latest Developments
Table 50. B. Braun Melsungen AG Company Summary
Table 51. B. Braun Melsungen AG Hemostatic Product Product Offerings
Table 52. B. Braun Melsungen AG Hemostatic Product Revenue (US$, Mn) & (2018-2023)
Table 53. B. Braun Melsungen AG Key News & Latest Developments
Table 54. Tricol Biomedical Company Summary
Table 55. Tricol Biomedical Hemostatic Product Product Offerings
Table 56. Tricol Biomedical Hemostatic Product Revenue (US$, Mn) & (2018-2023)
Table 57. Tricol Biomedical Key News & Latest Developments
Table 58. Hemostasis LL Company Summary
Table 59. Hemostasis LL Hemostatic Product Product Offerings
Table 60. Hemostasis LL Hemostatic Product Revenue (US$, Mn) & (2018-2023)
Table 61. Hemostasis LL Key News & Latest Developments
Table 62. Teleflex Incorporated Company Summary
Table 63. Teleflex Incorporated Hemostatic Product Product Offerings
Table 64. Teleflex Incorporated Hemostatic Product Revenue (US$, Mn) & (2018-2023)
Table 65. Teleflex Incorporated Key News & Latest Developments
Table 66. CuraMedical BV Company Summary
Table 67. CuraMedical BV Hemostatic Product Product Offerings
Table 68. CuraMedical BV Hemostatic Product Revenue (US$, Mn) & (2018-2023)
Table 69. CuraMedical BV Key News & Latest Developments
List of Figures
Figure 1. Hemostatic Product Segment by Type in 2022
Figure 2. Hemostatic Product Segment by Application in 2022
Figure 3. Global Hemostatic Product Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hemostatic Product Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Hemostatic Product Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hemostatic Product Revenue in 2022
Figure 8. By Type - Global Hemostatic Product Revenue Market Share, 2018-2029
Figure 9. By Application - Global Hemostatic Product Revenue Market Share, 2018-2029
Figure 10. By Type - Global Hemostatic Product Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Hemostatic Product Revenue Market Share, 2018-2029
Figure 12. By Application - Global Hemostatic Product Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Hemostatic Product Revenue Market Share, 2018-2029
Figure 14. By Region - Global Hemostatic Product Revenue Market Share, 2018-2029
Figure 15. By Country - North America Hemostatic Product Revenue Market Share, 2018-2029
Figure 16. US Hemostatic Product Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Hemostatic Product Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Hemostatic Product Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Hemostatic Product Revenue Market Share, 2018-2029
Figure 20. Germany Hemostatic Product Revenue, (US$, Mn), 2018-2029
Figure 21. France Hemostatic Product Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Hemostatic Product Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Hemostatic Product Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Hemostatic Product Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Hemostatic Product Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Hemostatic Product Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Hemostatic Product Revenue Market Share, 2018-2029
Figure 28. China Hemostatic Product Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Hemostatic Product Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Hemostatic Product Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Hemostatic Product Revenue, (US$, Mn), 2018-2029
Figure 32. India Hemostatic Product Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Hemostatic Product Revenue Market Share, 2018-2029
Figure 34. Brazil Hemostatic Product Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Hemostatic Product Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Hemostatic Product Revenue Market Share, 2018-2029
Figure 37. Turkey Hemostatic Product Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Hemostatic Product Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Hemostatic Product Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Hemostatic Product Revenue, (US$, Mn), 2018-2029
Figure 41. Medtronic Hemostatic Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Johnson & Johnson Hemostatic Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Baxter International Hemostatic Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Pfizer Inc. Hemostatic Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Becton Dickinson and Company (BD) Hemostatic Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. B. Braun Melsungen AG Hemostatic Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Tricol Biomedical Hemostatic Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Hemostasis LL Hemostatic Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Teleflex Incorporated Hemostatic Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. CuraMedical BV Hemostatic Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 止血製品の世界市場見通し2023年-2029年(Hemostatic Product Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

止血製品の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp